| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 8e-05 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |